Faten N. Aberra
Gastroenterology
3400 Civic Center Boulevard
South Pavilion, 4th Floor
Philadelphia, PA 19104
South Pavilion, 4th Floor
Philadelphia, PA 19104
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Homemade Microbrew: Auto-brewery Syndrome in a Patient with Crohn's Disease.
Journal: Digestive diseases and sciences
Published: April 26, 2026
Appropriate Use and Complications of Corticosteroids in Inflammatory Bowel Disease: A Comprehensive Review.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: January 20, 2025
Greater Fatigue and Reduced Neurocognitive Speed With Symptomatic Crohn's Disease.
Journal: Crohn's & colitis 360
Published: July 13, 2024
Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
Journal: Journal of Crohn's & colitis
Published: November 30, 2021
Influence of Corticosteroid Use on Short- and Long-Term Outcomes of Biologic Therapy for Inflammatory Bowel Diseases.
Journal: Digestive diseases and sciences
Published: August 27, 2021
The Impact of Introducing Patient-Reported Inflammatory Bowel Disease Symptoms via Electronic Survey on Clinic Visit Length, Patient and Provider Satisfaction, and the Environment Microbiome.
Journal: Inflammatory bowel diseases
Published: December 07, 2020
Indeterminate QuantiFERON-TB Gold Increases Likelihood of Inflammatory Bowel Disease Treatment Delay and Hospitalization.
Journal: Inflammatory bowel diseases
Published: April 07, 2017
Measurement of Inflammatory Bowel Disease Symptoms: Reliability of an Abbreviated Approach to Data Collection.
Journal: Inflammatory bowel diseases
Published: July 21, 2015
Can Colonoscopy Reduce the Risk of Colon Cancer and Mortality in Patients With Inflammatory Bowel Disease?
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 13, 2015
Mesalamine dose escalation reduces fecal calprotectin in patients with quiescent ulcerative colitis.
Mesalamine dose escalation reduces fecal calprotectin in patients with quiescent ulcerative colitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: March 21, 2014
Last Updated: 09/26/2026